Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Health Serv Res ; 54(2): 327-336, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30848491

RESUMO

OBJECTIVE: Medicare's Hospital Readmissions Reduction Program (HRRP) does not account for social risk factors in risk adjustment, and this may lead the program to unfairly penalize safety-net hospitals. Our objective was to determine the impact of adjusting for social risk factors on HRRP penalties. STUDY DESIGN: Retrospective cohort study. DATA SOURCES/STUDY SETTING: Claims data for 2 952 605 fee-for-service Medicare beneficiaries with acute myocardial infarction (AMI), congestive heart failure (CHF) or pneumonia from December 2012 to November 2015. PRINCIPAL FINDINGS: Poverty, disability, housing instability, residence in a disadvantaged neighborhood, and hospital population from a disadvantaged neighborhood were associated with higher readmission rates. Under current program specifications, safety-net hospitals had higher readmission ratios (AMI, 1.020 vs 0.986 for the most affluent hospitals; pneumonia, 1.031 vs 0.984; and CHF, 1.037 vs 0.977). Adding social factors to risk adjustment cut these differences in half. Over half the safety-net hospitals saw their penalty decline; 4-7.5 percent went from having a penalty to having no penalty. These changes translated into a $17 million reduction in penalties to safety-net hospitals. CONCLUSIONS: Accounting for social risk can have a major financial impact on safety-net hospitals. Adjustment for these factors could reduce negative unintended consequences of the HRRP.


Assuntos
Medicare/organização & administração , Readmissão do Paciente/estatística & dados numéricos , Risco Ajustado/organização & administração , Provedores de Redes de Segurança/organização & administração , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Pessoas com Deficiência/estatística & dados numéricos , Economia Hospitalar , Feminino , Disparidades nos Níveis de Saúde , Insuficiência Cardíaca/epidemiologia , Humanos , Revisão da Utilização de Seguros/estatística & dados numéricos , Masculino , Medicaid/estatística & dados numéricos , Medicare/normas , Infarto do Miocárdio/epidemiologia , Readmissão do Paciente/economia , Pneumonia/epidemiologia , Melhoria de Qualidade/organização & administração , Características de Residência/estatística & dados numéricos , Estudos Retrospectivos , Fatores de Risco , Provedores de Redes de Segurança/normas , Fatores Socioeconômicos , Estados Unidos
2.
Pain ; 94(1): 113-119, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11576750

RESUMO

The results of a considerable number of recent prospective studies have demonstrated that greater acute pain severity in herpes zoster patients is associated with a significantly greater risk of developing postherpetic neuralgia (PHN). Only a few studies have examined the relationships between acute pain severity and demographic characteristics and clinical features of patients with herpes zoster, however, and the results of these studies have been inconsistent. To clarify these relationships, data from 1778 herpes zoster patients studied within 72 h of rash onset in four clinical trials of the antiviral agent famciclovir were examined. Univariate and multivariate analyses indicated that greater acute pain severity was significantly associated with greater age, female sex, greater rash severity, the presence of a prodrome, and primary involvement of non-trigeminal dermatomes. These results demonstrate that three of the established risk factors for PHN - older age, greater rash severity, and the presence of a prodrome - are also associated with more severe acute pain assessed soon after rash onset in patients with herpes zoster. The results of this study are consistent with the recommendation that herpes zoster patients who are older, who have had a prodrome, or who have severe rash or severe acute pain should be targeted for interventions designed to prevent PHN.


Assuntos
2-Aminopurina , 2-Aminopurina/análogos & derivados , Antivirais , Bases de Dados Factuais , Herpes Zoster/epidemiologia , Dor/epidemiologia , 2-Aminopurina/uso terapêutico , Doença Aguda , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Antivirais/uso terapêutico , Bases de Dados Factuais/estatística & dados numéricos , Famciclovir , Feminino , Herpes Zoster/tratamento farmacológico , Herpes Zoster/fisiopatologia , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Dor/tratamento farmacológico , Dor/fisiopatologia , Fatores de Risco , Fatores Sexuais
3.
Health Aff (Millwood) ; 33(5): 786-91, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24799575

RESUMO

To better understand the degree to which risk-standardized thirty-day readmission rates may be influenced by social factors, we compared results for hospitals in Missouri under two types of models. The first type of model is currently used by the Centers for Medicare and Medicaid Services for public reporting of condition-specific hospital readmission rates of Medicare patients. The second type of model is an "enriched" version of the first type of model with census tract-level socioeconomic data, such as poverty rate, educational attainment, and housing vacancy rate. We found that the inclusion of these factors had a pronounced effect on calculated hospital readmission rates for patients admitted with acute myocardial infarction, heart failure, and pneumonia. Specifically, the models including socioeconomic data narrowed the range of observed variation in readmission rates for the above conditions, in percentage points, from 6.5 to 1.8, 14.0 to 7.4, and 7.4 to 3.7, respectively. Interestingly, the average readmission rates for the three conditions did not change significantly between the two types of models. The results of our exploratory analysis suggest that further work to characterize and report the effects of socioeconomic factors on standardized readmission measures may assist efforts to improve care quality and deliver more equitable care on the part of hospitals, payers, and other stakeholders.


Assuntos
Hospitais de Ensino/economia , Hospitais de Ensino/estatística & dados numéricos , Hospitais Urbanos/economia , Hospitais Urbanos/estatística & dados numéricos , Readmissão do Paciente/economia , Readmissão do Paciente/estatística & dados numéricos , Áreas de Pobreza , Adulto , Idoso , Centers for Medicare and Medicaid Services, U.S. , Estudos de Coortes , Feminino , Reforma dos Serviços de Saúde/economia , Humanos , Funções Verossimilhança , Masculino , Estado Civil , Pessoa de Meia-Idade , Missouri , Modelos Estatísticos , Estudos Retrospectivos , Medição de Risco/estatística & dados numéricos , Apoio Social , Fatores Socioeconômicos , Estados Unidos
6.
Neurology ; 65(12 Suppl 4): S59-65, 2005 Dec 29.
Artigo em Inglês | MEDLINE | ID: mdl-16385105

RESUMO

Placebo control use in clinical research is contentious in areas where effective treatments already exist. Determination of appropriate standards for placebo use is especially difficult in areas such as pain treatment and psychiatry, in which substantial placebo responses can occur. Debates are characterized by three common themes: (a) whether the state of existing treatments forbids placebo use, (b) whether the nature of the condition being treated and the level of additional risk permit placebo control use, and (c) whether methodological concerns are sufficient to justify placebo use. A review of these themes in the psychiatric research literature suggests possible strategies for analysis of this issue in the area of pain research.


Assuntos
Dor/tratamento farmacológico , Efeito Placebo , Psiquiatria/ética , Protocolos Clínicos/normas , Ensaios Clínicos como Assunto/ética , Ensaios Clínicos como Assunto/métodos , Ensaios Clínicos como Assunto/normas , Humanos , Transtornos Mentais/tratamento farmacológico , Dor/psicologia , Relações Médico-Paciente/ética , Psiquiatria/normas
7.
J Am Acad Dermatol ; 46(6): 834-9, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12063479

RESUMO

Baseline and follow-up data from 4 samples of immunocompetent patients with herpes zoster who participated in clinical trials of the antiviral agent famciclovir were examined (N = 1778). In both univariate and multivariate analyses, severe rash (ie, >50 lesions, defined as papules, vesicles, or crusted vesicles) was significantly associated with older age, male sex, severe pain, primary involvement of nontrigeminal dermatomes, and a greater number of affected dermatomes. In addition, severe rash predicted the presence of pain 3 months later. The results indicate that severe rash is more common in patients with herpes zoster who are older and who have more severe acute pain and confirm that severe rash is a risk factor for prolonged pain.


Assuntos
2-Aminopurina/análogos & derivados , Exantema/patologia , Herpes Zoster/patologia , Neuralgia/patologia , 2-Aminopurina/uso terapêutico , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Antivirais/uso terapêutico , Exantema/complicações , Famciclovir , Feminino , Herpes Zoster/complicações , Herpes Zoster/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Neuralgia/complicações , Medição da Dor , Ensaios Clínicos Controlados Aleatórios como Assunto , Índice de Gravidade de Doença , Fatores Sexuais , Nervo Trigêmeo
8.
J Med Virol ; 70 Suppl 1: S20-3, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12627482

RESUMO

Geographic and racial factors have been reported in studies of the epidemiology of varicella and herpes zoster. To clarify further these relationships, data from five multicenter clinical trials of the antiviral agent famciclovir were examined (total N = 2074). Non-Caucasian racial group and tropical region were each significantly associated with younger age at zoster onset. In analyses of the non-Caucasian subgroups, Black and Asian patients did not significantly differ in age or sex; however, Black and Asian patients from tropical regions had significantly younger mean ages at onset and greater rash duration at enrollment than those from temperate regions. Controlling for sex and rash duration at enrollment, both tropical region and non-Caucasian racial group were found to be independently associated with a younger age at zoster onset. These results suggest that racial group and geographic region may be independent factors associated with age at onset in patients with herpes zoster.


Assuntos
Herpes Zoster/epidemiologia , Adulto , Fatores Etários , Povo Asiático , População Negra , Fatores Epidemiológicos , Feminino , Herpes Zoster/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Clima Tropical , População Branca
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa